Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/22/13 → 11/30/17 |
Funding
- Genentech Incorporated: $119,104.40
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Multiple Doses of Mcmv5322a/Mcmv3068a For The Prevention Of Cytomegalovirus Disease In High Risk Kidney Allograft Recipients
- Quigg, Richard (PI)
- Pankewycz, Oleh (PI)
Project: Research